Skip to main content

Cearnal Martin E's Form 4 filing

Cumberland Pharmaceuticals Inc (CPIX) ยท filed Dec 3, 2021

Accession no.
0001209191-21-067878
Filed
Dec 3, 2021
Trade date
Nov 1-30, 2021
Filing delay
32 daysLate
Rule 10b5-1 plan
Not on the form (before 2023)

This filing lists 21 non-derivative transactions. Open-market purchases total $6.80K. It was filed 32 days after the trade, past the 2-business-day deadline.

Reporting owners

A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.

Reporting owners on this filing
OwnerRelationship to the company
Cearnal Martin ECIK 0001408500Director, Officer (Sr VP/Chief Commercial Officer)

Non-derivative securities (Table I)

Acquisitions and disposals of common stock and similar shares, one row per line on the filing.

Non-derivative transactions
Trade dateSecurityTransactionSharesPriceValueShares afterOwnershipFlags
Nov 1, 2021Common StockPPurchaseAcquired+105$2.67+$280.35173,979Direct
Nov 2, 2021Common StockPPurchaseAcquired+105$2.63+$276.15174,084Direct
Nov 3, 2021Common StockPPurchaseAcquired+105$2.71+$284.55174,189Direct
Nov 4, 2021Common StockPPurchaseAcquired+105$2.73+$286.65174,294Direct
Nov 5, 2021Common StockPPurchaseAcquired+105$2.71+$284.55174,399Direct
Nov 8, 2021Common StockPPurchaseAcquired+105$2.95+$309.75174,504Direct
Nov 9, 2021Common StockPPurchaseAcquired+105$3.21+$337.05174,609Direct
Nov 10, 2021Common StockPPurchaseAcquired+105$2.94+$308.7174,714Direct
Nov 11, 2021Common StockPPurchaseAcquired+105$2.83+$297.15174,819Direct
Nov 12, 2021Common StockPPurchaseAcquired+105$2.67+$280.35174,924Direct
Nov 15, 2021Common StockPPurchaseAcquired+105$2.71+$284.55175,029Direct
Nov 16, 2021Common StockPPurchaseAcquired+105$2.66+$279.3175,134Direct
Nov 17, 2021Common StockPPurchaseAcquired+105$2.58+$270.9175,239Direct
Nov 18, 2021Common StockPPurchaseAcquired+105$2.58+$270.9175,344Direct
Nov 19, 2021Common StockPPurchaseAcquired+105$2.55+$267.75175,449Direct
Nov 22, 2021Common StockPPurchaseAcquired+105$2.35+$246.75175,554Direct
Nov 23, 2021Common StockPPurchaseAcquired+105$2.29+$240.45175,659Direct
Nov 24, 2021Common StockPPurchaseAcquired+175$2.31+$404.25175,834Direct
Nov 26, 2021Common StockPPurchaseAcquired+175$2.26+$395.5176,009Direct
Nov 29, 2021Common StockPPurchaseAcquired+175$2.23+$390.25176,184Direct
Nov 30, 2021Common StockPPurchaseAcquired+175$4.61+$806.75176,359Direct

Footnotes and remarks

Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.

No transaction price on this filing refers to a footnote.

Read the full filing on SEC EDGAR (opens in a new tab)